Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: TopoTarget A/S
Woman and Man Max 99 years
TopoTarget A/S
Update Il y a 4 ans
A double-blind, randomised, parallel group, placebo-controlled dose finding Phase II study to compare the efficacy and safety of topically applied Avugane™ of different concentrations in subjects with mild to moderate acne vulgaris
The primary objective of the study is to compare the efficacy of different concentrations of the study treatment Avugane™ on facial papulopustular acne in comparison to a placebo control.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
TopoTarget A/S
Update Il y a 4 ans
A multi-centre, two-stage, open label phase II study to assess the efficacy and safety of APO866 in the treatment of patients with advanced melanoma
The primary objective of this clinical trial is to determine the anti-tumor activity of APO866 in patients with advanced cutaneous melanoma.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
TopoTarget A/S
Update Il y a 4 ans
APO866 for B-Cell Leukaemia. An open phase I/II clinical study assessing the safety and tolerability of APO866 in patients with refractory B-cell lymphocytic leukaemia not amenable to allogeneic hemopoietic stem cell transplantation
The main objectives of this study are: 1. To asses the safety and the tolerability of 1 cycle of APO866, administered by continuous intravenous infusion, in patients with refractory B-cell chronic ly...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
TopoTarget A/S
Update Il y a 4 ans
A Phase I/II Clinical Trial of PXD101 in Combination with Idarubicin in Patients with AML Not Suitable for Standard Intensive Therapy
The primary objective of this trial for the two schedules of PXD101 and idarubicin combination treatment is to determine the safety and tolerance (Maximum Tolerated Dose, Dose Limiting Toxicity) and ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
TopoTarget A/S
Update Il y a 4 ans
TOPOTARGET PXD101-CLN-17 : Essai de phase 2 randomisé comparant un traitement associant le carboplatine et le paclitaxel, avec ou sans belinostat, chez des patients ayant un cancer de primitif inconnu non préalablement traité. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
An open-label randomized phase II trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) compared to carboplatin and paclitaxel in patients with previously untreated carc...
Country
France
organs
Cancer de primitif inconnu (CAPI)
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman Max 99 years
TopoTarget A/S
Update Il y a 4 ans
A Phase I/II Safety, Pharmacodynamic, and Pharmacokinetic Study of Intravenously Administered PXD101 Plus Carboplatin or Paclitaxel or Both in Patients with Advanced Solid Tumours
Following establishment of MTD up to a total of 32 patients with epithelial ovarian, primary peritoneal, fallopian tube or mixed mullerian tumours of ovarian origin may be enrolled at the MTD dose lev...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2